1-3 of 3 results for subject:Haemolysis
Librarians' tools
- Search time
- 0.189 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Haemolysis
- We searched for
- subject_t:Haemolysis OR subject_ses:564862
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, how many sickle cell patients who had complications due to sickle cell listed as their cause of death experienced haemolysis in the period before their death in the last 12 months.
To ask the Secretary of State for Health and Social Care, how many sickle cell patients who had complications due to sickle cell listed as their cause of death experienced haemolysis in the period before their death in the last 12 months.
The Department does not hold this information. NHS England does not hold or have access to data that would accurately represent the number of sickle cell patients that have died due to complications due to sickle cell in the last 12 months, or how many of those patients experienced haemolysis in the period before their death in the last 12 months.
The National Disease Registration Service, part of NHS England, is expanding its rare disease collection to include patients with sickle cell disorder (SCD) in England. This will form a comprehensive national dataset to enable improved understanding of patient pathways for SCD, support planning and commissioning of services and improve patient outcomes.
To ask the Secretary of State for Health and Social Care, , how many sickle cell patients have developed haemolysis due to receiving a blood transfusion with unmatched blood during the last 12 months.
To ask the Secretary of State for Health and Social Care, , how many sickle cell patients have developed haemolysis due to receiving a blood transfusion with unmatched blood during the last 12 months.
Serious Hazards of Transfusion (SHOT) is the United Kingdom’s independent, professionally led haemovigilance scheme. SHOT collects and analyses information on adverse events and reactions in blood transfusion from all healthcare organisations that are involved in the transfusion of blood components and specific blood products in the United Kingdom. Further information on SHOT is available at the following link:
The latest data available on haemolytic transfusion reactions was published in the Annual SHOT Report 2024. The report reviews reactions reported to SHOT from January to December 2024, and is available at the following link:
https://www.shotuk.org/shot-reports/annual-shot-report-2024/#annual-shot
Over the year, based on the available data, a total of 51 haemolytic transfusion reactions were reported. No errors were reported during the provision of blood components, meaning in all cases blood was appropriately matched, including safe substitutions where necessary, according to the patient requirements and clinical situation, as per British Society for Haematology’s guidelines, which are available at the following link:
To ask the Secretary of State for Health and Social Care, how many patients with (a) leukaemia and lymphoma, (b) myeloma, (c) other cancers, (d) myelodysplastic syndromes, (e) aplastic anemia, (f) thalassemia, (g) bleeding disorders and (h) other conditions which require regular blood transfusions have developed haemolysis due to receiving...
To ask the Secretary of State for Health and Social Care, how many patients with (a) leukaemia and lymphoma, (b) myeloma, (c) other cancers, (d) myelodysplastic syndromes, (e) aplastic anemia, (f) thalassemia, (g) bleeding disorders and (h) other conditions which require regular blood transfusions have developed haemolysis due to receiving...
Serious Hazards of Transfusion (SHOT) is the United Kingdom’s independent, professionally led haemovigilance scheme. SHOT collects and analyses information on adverse events and reactions in blood transfusion from all healthcare organisations that are involved in the transfusion of blood components and specific blood products in the United Kingdom. Further information on SHOT is available at the following link:
The latest data available on haemolytic transfusion reactions was published in the Annual SHOT Report 2024. The report reviews reactions reported to SHOT from January to December 2024, and is available at the following link:
https://www.shotuk.org/shot-reports/annual-shot-report-2024/#annual-shot
Over the year, based on the available data, a total of 51 haemolytic transfusion reactions were reported. No errors were reported during the provision of blood components, meaning in all cases blood was appropriately matched, including safe substitutions where necessary, according to the patient requirements and clinical situation, as per British Society for Haematology’s guidelines, which are available at the following link: